Tag: David Pernock

December 10, 2018

Genetics Outlook 2019: CRISPR Technology Advances

With 2018 coming to a close, here's a look at the biggest genetics trends of the year and what's in...
January 5, 2017

Genetics Outlook 2017: The Revolution Nears

You've heard it before ... but this time, it really does look like the gene therapy revolution is drawing near.
December 30, 2016

Top Trends for Genetics Stocks in 2017

What can you expect from genetics stocks in 2017? We touched base with those in the know to bring you...
December 19, 2016

Fibrocell Announces Leadership Changes

Fibrocell Science today announced that John Maslowski has been appointed Chief Executive Officer (CEO) and Douglas Swirsky has been appointed...
November 10, 2016

Fibrocell Appoints Alfred T. Lane, MD, Chief Medical Advisor

Fibrocell Science today announced the appointment of Alfred T. Lane, MD, as Chief Medical Advisor of Fibrocell.
September 8, 2016

Fibrocell Science Closes $18.1 Million Financing Deal

Fibrocell Science, a relatively small gene therapy company, just closed a huge financing deal: it received $18.1 million after selling...
April 18, 2016

Fibrocell and Intrexon Announce Allowance to Commence Phase I/II Trial for FCX-007 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)

– Phase I/II Clinical Trial to Begin in Second Quarter of 2016 – EXTON, Pa. and GERMANTOWN, Md., April 18,...